Estradiol, CCK and satiation.
Estradiol has long been known to inhibit feeding in animals, but the mechanism(s) mediating its effects have not been clear. Demonstrations that estradiol's feeding effects are expressed as decreases in meal size coupled with the emerging consensus that cholecystokinin (CCK) released from the small intestines during meals is a physiological negative-feedback signal controlling meal size (i.e. satiation) suggested a new approach to the problem of the mechanisms of estradiol's inhibitory effect on feeding. Progress on this approach is reviewed here. Experimental manipulations of exogenous and endogenous CCK and estradiol have produced converging evidence that estradiol cyclically increases the activity of the CCK satiation-signaling pathway so that meal size and food intake decrease during the ovulatory or estrus phase of the ovarian cycle. This is a striking example of the modulation of the operation of a control of meal size by the physiological context in which the meal occurs. Estradiol also produces a tonic decrease in meal size, but this apparently does not involve the CCK satiation-signaling pathway. Where and how estradiol acts to increase the potency of the CCK satiating-signaling pathway are not known. Several possible sites are suggested by the observations that estradiol treatment increases feeding- and CCK-induced expression of c-Fos in ovariectomized animals in brain areas including the nucleus tractus solitarius, paraventricular nucleus of the hypothalamus, and central nucleus of the amygdala. Tests with null mutation mice indicate that estrogen receptor-alpha is necessary for estradiol's feeding effects. Finally, the possibilities that estradiol exerts important influences on normal or disordered eating in women are discussed. It is concluded that estradiol exerts a biologically significant action on CCK satiation in animals. Further research to determine whether this action of estradiol has a role in the pathogenesis, course, or treatment of disordered eating in women is indicated.
Geary
N
N
Weill Medical College of Cornell University, E. W. Bourne Laboratory, Department of Psychiatry, 21 Bloomingdale Road, White Plains, NY 10605, USA. ndgeary@med.cornell.edu
D000818:Animals; D001921:Brain / Q000378:metabolism; D002766:Cholecystokinin / Q000378:metabolism* / Q000502:physiology*; D004958:Estradiol / Q000378:metabolism* / Q000502:physiology*; D005247:Feeding Behavior; D001068:Feeding and Eating Disorders; D005260:Female; D006801:Humans; D007031:Hypothalamus / Q000378:metabolism; D010060:Ovulation; D012527:Satiation; D015398:Signal Transduction; D013997:Time Factors
D004958:Estradiol; D002766:Cholecystokinin